These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2501026

  • 1. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
    Claverie N, Mamont PS.
    Cancer Res; 1989 Aug 15; 49(16):4466-71. PubMed ID: 2501026
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.
    Pera PJ, Kramer DL, Sufrin JR, Porter CW.
    Cancer Res; 1986 Mar 15; 46(3):1148-54. PubMed ID: 3080234
    [Abstract] [Full Text] [Related]

  • 3. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
    Bowlin TL, Hoeper BJ, Rosenberger AL, Davis GF, Sunkara PS.
    Cancer Res; 1990 Aug 01; 50(15):4510-4. PubMed ID: 2114941
    [Abstract] [Full Text] [Related]

  • 4. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
    Bartholeyns J, Mamont P, Casara P.
    Cancer Res; 1984 Nov 01; 44(11):4972-7. PubMed ID: 6435861
    [Abstract] [Full Text] [Related]

  • 5. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M, Chan D, Freireich EJ, Marton LJ, Zwelling LA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [Abstract] [Full Text] [Related]

  • 6. Comparison and characterization of growth inhibition in L1210 cells by alpha-difluoromethylornithine, an inhibitor of ornithine decarboxylase, and N1,N8-bis(ethyl)spermidine, an apparent regulator of the enzyme.
    Porter CW, Ganis B, Vinson T, Marton LJ, Kramer DL, Bergeron RJ.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6279-85. PubMed ID: 3096560
    [Abstract] [Full Text] [Related]

  • 7. Marked and prolonged inhibition of mammalian ornithine decarboxylase in vivo by esters of (E)-2-(fluoromethyl)dehydroornithine.
    Mamont PS, Danzin C, Kolb M, Gerhart F, Bey P, Sjoerdsma A.
    Biochem Pharmacol; 1986 Jan 15; 35(2):159-65. PubMed ID: 3080004
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of norspermidine, a structural homologue of the natural polyamine spermidine.
    Prakash NJ, Bowlin TL, Davis GF, Sunkara PS, Sjoerdsma A.
    Anticancer Res; 1988 Jan 15; 8(4):563-8. PubMed ID: 3140710
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of ornithine decarboxylase activity and cell growth by diamines: a comparison between the effects of two homologs, 1,3-diaminopropane and 1,4-diaminobutane (putrescine).
    Linden M, Oredsson SM, Anehus S, Heby O.
    J Cell Biochem; 1985 Jan 15; 29(2):105-13. PubMed ID: 3934184
    [Abstract] [Full Text] [Related]

  • 10. Properties of L1210 cells resistant to alpha-difluoromethylornithine.
    Pegg AE, Secrist JA, Madhubala R.
    Cancer Res; 1988 May 15; 48(10):2678-82. PubMed ID: 3129184
    [Abstract] [Full Text] [Related]

  • 11. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
    Sunkara PS, Rosenberger AL.
    Cancer Res; 1987 Feb 15; 47(4):933-5. PubMed ID: 3100031
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
    Casero RA, Go B, Theiss HW, Smith J, Baylin SB, Luk GD.
    Cancer Res; 1987 Aug 01; 47(15):3964-7. PubMed ID: 3038303
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS, Prakash NJ, Rosenberger AL, Hagan AC, Lachmann PJ, Mayer GD.
    Cancer Res; 1984 Jul 01; 44(7):2799-802. PubMed ID: 6426786
    [Abstract] [Full Text] [Related]

  • 14. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice.
    Sunkara PS, Bowlin TL, Rosenberger AL, Fleischmann WR.
    J Biol Response Mod; 1989 Apr 01; 8(2):170-9. PubMed ID: 2499664
    [Abstract] [Full Text] [Related]

  • 15. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW.
    Cancer Res; 1994 Jun 15; 54(12):3210-7. PubMed ID: 8205541
    [Abstract] [Full Text] [Related]

  • 16. Decarboxylated-S-adenosylmethionine excretion: a biochemical marker of ornithine decarboxylase inhibition by alpha-difluoromethylornithine.
    Haegele KD, Splinter TA, Romijn JC, Schechter PJ, Sjoerdsma A.
    Cancer Res; 1987 Feb 01; 47(3):890-5. PubMed ID: 3100028
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice.
    Claverie N, Pasquali JL, Mamont PS, Danzin C, Weil-Bousson M, Siat M.
    Clin Exp Immunol; 1988 May 01; 72(2):293-8. PubMed ID: 3409547
    [Abstract] [Full Text] [Related]

  • 18. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
    Luk GD, Abeloff MD, McCann PP, Sjoerdsma A, Baylin SB.
    Cancer Res; 1986 Apr 01; 46(4 Pt 1):1849-53. PubMed ID: 3004708
    [Abstract] [Full Text] [Related]

  • 19. D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells.
    Choudhary SK, Sharma D, Dixit A.
    Cell Biol Int; 1999 Apr 01; 23(7):489-95. PubMed ID: 10728786
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.
    Takigawa M, Verma AK, Simsiman RC, Boutwell RK.
    Cancer Res; 1983 Aug 01; 43(8):3732-8. PubMed ID: 6407752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.